Sensible use of high-sensitivity troponin assays

Methods in Molecular Biology

Volumn 963, Issue , 2013, Pages 385-406

  Hof, Danielle ^a   Klingenberg, Roland ^a   Von Eckardstein, Arnold ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Acute coronary syndrome; Calcium; Cardiac troponin; Cardiovascular disease; EF hand; High sensitivity assay; Laboratory medicine; NSTEMI; STEMI

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SENSIBILITY; SYMPTOMATOLOGY; ANIMAL; BLOOD; BLOOD ANALYSIS; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

ACUTE CORONARY SYNDROME; ANIMALS; BLOOD CHEMICAL ANALYSIS; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 84878750717     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-230-8_24     Document Type: Chapter

References (77)

1. Schaub MC, Heizmann CW (2008) Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies. Biochem Biophys Res Commun 369:247–264.
2. Cummins B, Auckland ML, Cummins P (1987) Cardiac-speci fic troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 113:1333–1344.
3. Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80:853–924.
4. Manning EP, TardiffJC, Schwartz SD (2011) A model of calcium activation of the cardiac thin filament. Biochemistry 50:7405–7413.
5. Jin JP, Zhang Z, Bautista JA (2008) Isoform diversity, regulation, and functional adaptation of troponin and calponin. Crit Rev Eukaryot Gene Expr 18:93–124.
6. Wei B, Jin JP (2011) Troponin T isoforms and posttranscriptional modi fications: evolution, regulation and function. Arch Biochem Biophys 505:144–154.
7. Solaro RJ, van der Velden J (2010) Why does troponin I have so many phosphorylation sites? Fact and fancy. J Mol Cell Cardiol 48:810–816.
8. Zhang J et al (2011) Phosphorylation, but not alternative splicing or proteolytic degradation, is conserved in human and mouse cardiac troponin T. Biochemistry 50:6081–6092.
9. Di Lisa F et al (1995) Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation. Biochem J 308:57–61.
10. Stary HC et al (1995) A definition of advanced types of atherosclerotic lesions and a histological classi fication of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355–1374.
11. Stary HC et al (1994) A de finition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:2462–2478.
12. Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473:317–325.
13. Libby P (2009) Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis. J Lipid Res 50(Suppl):S352–357.
14. Arbustini E et al (1999) Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 82:269–272.
15. Hamm CW et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of. Cardiology (ESC). Eur Heart J 32:2999–3054.
16. Rioufol G et al (2002) Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106:804–808.
17. Naghavi M et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108:1772–1778.
18. Naghavi M et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108:1664–1672.
19. Van de Werf F et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29:2909–2945.
20. Bleier J et al (1998) Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage. Clin Chem 44:1912–1918.
21. Gerhardt W et al (1991) S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 37:1405–1411.
22. Morrow DA et al (2007) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115:e356–375.
23. Thomas L (2005) Labor und Diagnose, 6th edn. TH-Books Verlagsgesellschaft, Frankfurt.
24. Apple FS et al (2007) National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 53:547–551.
25. Morrow DA et al (2007) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53:552–574.
26. Anderson JL et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:e148–304.
27. Saenger AK, Jaffe AS (2008) Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation 118:2200–2206.
28. Thygesen K et al (2007) Universal de finition of myocardial infarction. Circulation 116:2634–2653.
29. Collinson P et al (2008) How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study. Clin Chem 54:448–449.
30. Collinson P et al (2011) Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem 58:305–306.
31. Than M et al (2011) A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet 377:1077–1084.
32. Bates KJ et al (2010) Circulating immunoreactive cardiac troponin forms determined by gelfiltration chromatography after acute myocardial infarction. Clin Chem 56:952–958.
33. Giuliani I et al (1999) Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia. Clin Chem 45:213–222.
34. Katrukha AG et al (1997) Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 43:1379–1385.
35. Wu AH et al (1998) Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 44:1198–1208.
36. Katrukha AG et al (1998) Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 44:2433–2440.
37. McDonough JL, Arrell DK, Van Eyk JE (1999) Troponin I degradation and covalent complex formation accompanies myocardial ischemia/ reperfusion injury. Circ Res 84:9–20.
38. McDonough JL et al (2001) Cardiac troponin I is modified in the myocardium of bypass patients. Circulation 103:58–64.
39. Labugger R et al (2000) Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 102:1221–1226.
40. Tate JR et al (2010) Standardisation of cardiac troponin I measurement: past and present. Pathology 42:402–408.
41. Koshida S et al (2010) Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations. Clin Chim Acta 411:391–394.
42. Todd DJ et al (2011) Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum 63:894–903.
43. Eriksson S et al (2005) Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 51:839–847.
44. Eriksson S et al (2005) Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem 51:848–855.
45. Adamczyk M, Brashear RJ, Mattingly PG (2009) Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann N Y Acad Sci 1173:67–74.
46. Adamczyk M, Brashear RJ, Mattingly PG (2009) Prevalence of autoantibodies to cardiac troponin T in healthy blood donors. Clin Chem 55:1592–1593.
47. Adamczyk M, Brashear RJ, Mattingly PG (2010) Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors. Clin Chem 56:676–677.
48. Body R et al (2011) Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 58:1332–1339.
49. Januzzi JL et al (2010) High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 121:1227–1234.
50. Antman EM et al (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284:835–842.
51. Eagle KA et al (2004) A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291:2727–2733.
52. Morrow DA et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031–2037.
53. Morrow DA et al (2001) Ability of minor elevations of troponins I and T to predict bene fit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 286:2405–2412.
54. Apple FS et al (2009) Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 55:930–937.
55. th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol 100:1077–1085.
56. Kavsak PA et al (2009) Short- and long-term risk strati fication using a next-generation, high-sensitivity research cardiac troponin I (hscTnI) assay in an emergency department chest pain population. Clin Chem 55:1809–1815.
57. Kurz K et al (2011) Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identi fication of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol 100:209–215.
58. Lindahl B, Venge P, James S (2010) The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J 160:224–229.
59. O’Connor RE et al (2010) Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122:S787–817.
60. Scirica BM et al (2011) Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Eur Heart J 32:697–705.
61. Hochholzer W et al (2011) Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction. Clin Chem 57:1318–1326.
62. Meune C et al (2011) The GRACE score’s performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Heart 97:1479–1483.
63. Ndrepepa G et al. (2011) Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes. Clin Chim Acta 412: 1350–1356.
64. Mills NL et al (2011) Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 305:1210–1216.
65. KorffS, Katus HA, Giannitsis E (2006) Differential diagnosis of elevated troponins. Heart 92:987–993.
66. Roongsritong C, Warraich I, Bradley C (2004) Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 125:1877–1884.
67. Omland T et al (2009) A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 361:2538–2547.
68. Reiter M et al (2011) Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 33:988–997. doi:10.1093/eurheartj/ehr376, E-pub ahead of print.
69. Aviles RJ et al (2002) Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 346:2047–2052.
70. Apple FS et al (2002) Predictive value of cardiac troponin I and T for subsequent death in endstage renal disease. Circulation 106:2941–2945.
71. Dierkes J et al (2000) Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102:1964–1969.
72. Ooi DS et al (1999) Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. Clin Biochem 32:647–652.
73. Reiter M et al (2011) Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 32:1379–1389.
74. Hickman PE et al (2010) Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta 411:318–323.
75. Saunders JT et al (2011) Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123: 1367–1376.
76. de Lemos JA et al (2010) Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304:2503–2512.
77. Blankenberg S et al (2010) Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 121:2388–2397.